EARLY POSTTREATMENT WITH PENTOXIFYLLINE OR DIBUTYRYL CAMP ATTENUATES ESCHERICHIA-COLI-INDUCED ACUTE LUNG INJURY IN GUINEA-PIGS

We examined effects of early post-treatment with the methylxanthine pentoxifylline (PTXF), or the cell-permeable adenosine 3', 5' -cyclic monophosphate (cAMP) analog dibutyryl cAMP (db-cAMP) on Escherichia-coli-induced acute lung injury in guinea pigs. Acute lung injury was assessed by measurements of lung water (lung wet/dry weight ratio; W/D ratio), the concentration ratio of I-125-albumin in bronchoalveolar lavage (BAL) fluid and lung tissue compared with plasma (albumin index; BAL-Al or tissue-Al), and total differential leukocyte count in BAL fluid. Mean arterial pressure (PaBAR) and peripheral WBC counts were monitored continuously over the 8-h experiment. Septicemia was induced by a bolus injection of 2 x 10(9)/kg live E. coli. Thirty minutes later the animals received a bolus injection followed by continuous infusion of PTXF (20 mg/kg + 20 mg/kg/h; n = 8) or db-cAMP (2 mg/kg + 2 mg/kg/h; n = 8) or saline (septic control; n = 8). Nonseptic control groups were also studied. The lung W/D ratio, BAL-Al, lung tissue-Al, and BAL leukocyte count increased significantly in the septic control group. The PTXF-septic and db-cAMP-septic groups showed no significant increase in lung W/D ratio, BAL-Al, and lung tissue-Al. However, there was no difference in BAL total and differential leukocyte count as compared with the septic control group. PTXF and db-cAMP had no effect on E. coli-induced changes in peripheral WBC count and PaBAR. Companion in vitro experiments demonstrated that PTXF and db-cAMP inhibited the endotoxin-induced (E. coli) chemiluminescent response of isolated guinea-pig polymorphonuclear leukocytes (PMN). These results indicate that early post-treatment with PTXF or db-cAMP attenuates E. coli-induced acute lung injury in guinea pigs. Because PTXF and db-cAMP markedly reduce endotoxin-induced PMN chemiluminescence, they may attenuate acute lung injury in part by inhibiting PMN activation. Additionally, because PTXF and db-cAMP were administered after the septic insult, they may have therapeutic potential.